196 related articles for article (PubMed ID: 21584652)
21. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
22. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic characteristics of sporadic Japanese Creutzfeldt-Jakob disease classified according to prion protein gene polymorphism and prion protein type.
Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
Acta Neuropathol; 2006 Nov; 112(5):561-71. PubMed ID: 16847689
[TBL] [Abstract][Full Text] [Related]
24. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
25. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
[TBL] [Abstract][Full Text] [Related]
26. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
[TBL] [Abstract][Full Text] [Related]
27. Characterisation and prion transmission study in mice with genetic reduction of sporadic Creutzfeldt-Jakob disease risk gene Stx6.
Jones E; Hill E; Linehan J; Nazari T; Caulder A; Codner GF; Hutchison M; Mackenzie M; Farmer M; Coysh T; De Oliveira MW; Al-Doujaily H; Sandberg M; Viré E; Cunningham TJ; Asante EA; Brandner S; Collinge J; Mead S
Neurobiol Dis; 2024 Jan; 190():106363. PubMed ID: 37996040
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathology of human prion diseases.
Kovacs GG; Budka H
Int J Mol Sci; 2009 Mar; 10(3):976-99. PubMed ID: 19399233
[TBL] [Abstract][Full Text] [Related]
29. The prion strain phenomenon: molecular basis and unprecedented features.
Morales R; Abid K; Soto C
Biochim Biophys Acta; 2007 Jun; 1772(6):681-91. PubMed ID: 17254754
[TBL] [Abstract][Full Text] [Related]
30. Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.
Pirisinu L; Nonno R; Esposito E; Benestad SL; Gambetti P; Agrimi U; Zou WQ
PLoS One; 2013; 8(6):e66405. PubMed ID: 23826096
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of sporadic prion diseases in man.
Safar JG
Prion; 2012; 6(2):108-15. PubMed ID: 22421210
[TBL] [Abstract][Full Text] [Related]
32. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.
Zanusso G; Farinazzo A; Prelli F; Fiorini M; Gelati M; Ferrari S; Righetti PG; Rizzuto N; Frangione B; Monaco S
J Biol Chem; 2004 Sep; 279(37):38936-42. PubMed ID: 15247220
[TBL] [Abstract][Full Text] [Related]
33. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes.
Kovács GG; Head MW; Hegyi I; Bunn TJ; Flicker H; Hainfellner JA; McCardle L; László L; Jarius C; Ironside JW; Budka H
Brain Pathol; 2002 Jan; 12(1):1-11. PubMed ID: 11770893
[TBL] [Abstract][Full Text] [Related]
35. Sporadic Creutzfeldt-Jakob Disease: Prion Pathology in Medulla Oblongata-Possible Routes of Infection and Host Susceptibility.
Iacono D; Ferrari S; Gelati M; Zanusso G; Mariotto S; Monaco S
Biomed Res Int; 2015; 2015():396791. PubMed ID: 26457299
[TBL] [Abstract][Full Text] [Related]
36. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
[TBL] [Abstract][Full Text] [Related]
37. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
38. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG
PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554
[TBL] [Abstract][Full Text] [Related]
39. Variably Protease-sensitive Prionopathy in a Middle-aged Man With Rapidly Progressive Dementia.
Huang J; Cohen M; Safar J; Auchus AP
Cogn Behav Neurol; 2021 Sep; 34(3):220-225. PubMed ID: 34473674
[TBL] [Abstract][Full Text] [Related]
40. Human prion diseases: An overview.
Piñar-Morales R; Barrero-Hernández F; Aliaga-Martínez L
Med Clin (Barc); 2023 Jun; 160(12):554-560. PubMed ID: 37088611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
